{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T05:12:46Z","timestamp":1770354766149,"version":"3.49.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1743-422x-11-176","type":"journal-article","created":{"date-parts":[[2014,10,6]],"date-time":"2014-10-06T13:01:24Z","timestamp":1412600484000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sequencing and molecular characterization of CTNCEC25, a China fixed rabies virus vaccine strain CTN-1 adapted to primary chicken embryo cells"],"prefix":"10.1186","volume":"11","author":[{"given":"Shimao","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caiping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,6]]},"reference":[{"key":"2503_CR1","first-page":"45","volume":"292","author":"B Dietzschold","year":"2005","unstructured":"Dietzschold B, Schnell M, Koprowski H: Pathogenesis of rabies. Curr Top Microbiol Immunol 2005, 292: 45-56.","journal-title":"Curr Top Microbiol Immunol"},{"key":"2503_CR2","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.3201\/eid1112.040775","volume":"11","author":"YZ Zhang","year":"2005","unstructured":"Zhang YZ, Xiong CL, Xiao DL, Jiang RJ, Wang ZX, Zhang LZ, Fu ZF: Human rabies in China. Emerg Infect Dis 2005, 11: 1983-1984. 10.3201\/eid1112.040775","journal-title":"Emerg Infect Dis"},{"key":"2503_CR3","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1073\/pnas.83.11.3914","volume":"83","author":"N Tordo","year":"1986","unstructured":"Tordo N, Poch O, Ermine A, Keith G, Rougeon F: Walking along the rabies genome: is the large G-L intergenic region a remnant gene? Proc Natl Acad Sci U S A 1986, 83: 3914-3918. 10.1073\/pnas.83.11.3914","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2503_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-387040-7.00001-9","volume":"79","author":"AA Albertini","year":"2011","unstructured":"Albertini AA, Ruigrok RW, Blondel D: Rabies virus transcription and replication. Adv Virus Res 2011, 79: 1-22.","journal-title":"Adv Virus Res"},{"key":"2503_CR5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/JVI.73.1.242-250.1999","volume":"73","author":"T Mebatsion","year":"1999","unstructured":"Mebatsion T, Weiland F, Conzelmann KK: Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G. J Virol 1999, 73: 242-250.","journal-title":"J Virol"},{"key":"2503_CR6","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/S0092-8674(00)81072-7","volume":"84","author":"T Mebatsion","year":"1996","unstructured":"Mebatsion T, Konig M, Conzelmann KK: Budding of rabies virus particles in the absence of the spike glycoprotein. Cell 1996, 84: 941-951. 10.1016\/S0092-8674(00)81072-7","journal-title":"Cell"},{"key":"2503_CR7","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/iai.16.3.754-759.1977","volume":"16","author":"JH Cox","year":"1977","unstructured":"Cox JH, Dietzschold B, Schneider LG: Rabies virus glycoprotein. II. Biological and serological characterization. Infect Immun 1977, 16: 754-759.","journal-title":"Infect Immun"},{"key":"2503_CR8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4049\/jimmunol.110.1.269","volume":"110","author":"TJ Wiktor","year":"1973","unstructured":"Wiktor TJ, Gyorgy E, Schlumberger D, Sokol F, Koprowski H: Antigenic properties of rabies virus components. J Immunol 1973, 110: 269-276.","journal-title":"J Immunol"},{"key":"2503_CR9","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/BF01718609","volume":"141","author":"JH Zhu","year":"1996","unstructured":"Zhu JH, Wang J, Cai B, Zhao W, Zhu Y, Chao R, Chen L, Xue H, Ying BL, Li CP, Hu QL, Sha J, Esposito JJ: Immunogenicity and relative attenuation of different vaccinia-rabies virus recombinants. Arch Virol 1996, 141: 1055-1065. 10.1007\/BF01718609","journal-title":"Arch Virol"},{"key":"2503_CR10","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1128\/JVI.76.7.3374-3381.2002","volume":"76","author":"M Faber","year":"2002","unstructured":"Faber M, Pulmanausahakul R, Hodawadekar SS, Spitsin S, McGettigan JP, Schnell MJ, Dietzschold B: Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response. J Virol 2002, 76: 3374-3381. 10.1128\/JVI.76.7.3374-3381.2002","journal-title":"J Virol"},{"key":"2503_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1073\/pnas.80.1.70","volume":"80","author":"B Dietzschold","year":"1983","unstructured":"Dietzschold B, Wunner WH, Wiktor TJ, Lopes AD, Lafon M, Smith CL, Koprowski H: Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc Natl Acad Sci U S A 1983, 80: 70-74. 10.1073\/pnas.80.1.70","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2503_CR12","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/JVI.73.1.510-518.1999","volume":"73","author":"K Morimoto","year":"1999","unstructured":"Morimoto K, Hooper DC, Spitsin S, Koprowski H, Dietzschold B: Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures. J Virol 1999, 73: 510-518.","journal-title":"J Virol"},{"key":"2503_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3109\/13550280009018301","volume":"6","author":"K Morimoto","year":"2000","unstructured":"Morimoto K, Foley HD, McGettigan JP, Schnell MJ, Dietzschold B: Reinvestigation of the role of the rabies virus glycoprotein in viral pathogenesis using a reverse genetics approach. J Neurovirol 2000, 6: 373-381. 10.3109\/13550280009018301","journal-title":"J Neurovirol"},{"key":"2503_CR14","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/jvi.53.3.926-934.1985","volume":"53","author":"I Seif","year":"1985","unstructured":"Seif I, Coulon P, Rollin PE, Flamand A: Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J Virol 1985, 53: 926-934.","journal-title":"J Virol"},{"key":"2503_CR15","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1126\/science.6494916","volume":"226","author":"TL Lentz","year":"1984","unstructured":"Lentz TL, Wilson PT, Hawrot E, Speicher DW: Amino acid sequence similarity between rabies virus glycoprotein and snake venom curaremimetic neurotoxins. Science 1984, 226: 847-848. 10.1126\/science.6494916","journal-title":"Science"},{"key":"2503_CR16","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1128\/JVI.72.9.7181-7190.1998","volume":"72","author":"MI Thoulouze","year":"1998","unstructured":"Thoulouze MI, Lafage M, Schachner M, Hartmann U, Cremer H, Lafon M: The neural cell adhesion molecule is a receptor for rabies virus. J Virol 1998, 72: 7181-7190.","journal-title":"J Virol"},{"key":"2503_CR17","doi-asserted-by":"publisher","first-page":"37655","DOI":"10.1074\/jbc.M201374200","volume":"277","author":"C Langevin","year":"2002","unstructured":"Langevin C, Jaaro H, Bressanelli S, Fainzilber M, Tuffereau C: Rabies virus glycoprotein (RVG) is a trimeric ligand for the N-terminal cysteine-rich domain of the mammalian p75 neurotrophin receptor. J Biol Chem 2002, 277: 37655-37662. 10.1074\/jbc.M201374200","journal-title":"J Biol Chem"},{"key":"2503_CR18","doi-asserted-by":"publisher","first-page":"7250","DOI":"10.1093\/emboj\/17.24.7250","volume":"17","author":"C Tuffereau","year":"1998","unstructured":"Tuffereau C, Benejean J, Blondel D, Kieffer B, Flamand A: Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus. EMBO J 1998, 17: 7250-7259. 10.1093\/emboj\/17.24.7250","journal-title":"EMBO J"},{"key":"2503_CR19","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1128\/jvi.65.8.4198-4203.1991","volume":"65","author":"A Benmansour","year":"1991","unstructured":"Benmansour A, Leblois H, Coulon P, Tuffereau C, Gaudin Y, Flamand A, Lafay F: Antigenicity of rabies virus glycoprotein. J Virol 1991, 65: 4198-4203.","journal-title":"J Virol"},{"key":"2503_CR20","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1128\/jvi.64.8.3804-3809.1990","volume":"64","author":"B Dietzschold","year":"1990","unstructured":"Dietzschold B, Gore M, Marchadier D, Niu HS, Bunschoten HM, Otvos L Jr, Wunner WH, Ertl HC, Osterhaus AD, Koprowski H: Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine. J Virol 1990, 64: 3804-3809.","journal-title":"J Virol"},{"issue":"Pt 8","key":"2503_CR21","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1099\/0022-1317-74-8-1539","volume":"74","author":"RW van der Heijden","year":"1993","unstructured":"van der Heijden RW, Langedijk JP, Groen J, UytdeHaag FG, Meloen RH, Osterhaus AD: Structural and functional studies on a unique linear neutralizing antigenic site (G5) of the rabies virus glycoprotein. J Gen Virol 1993,74(Pt 8):1539-1545.","journal-title":"J Gen Virol"},{"key":"2503_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/jvi.62.1.1-7.1988","volume":"62","author":"C Prehaud","year":"1988","unstructured":"Prehaud C, Coulon P, LaFay F, Thiers C, Flamand A: Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence. J Virol 1988, 62: 1-7.","journal-title":"J Virol"},{"key":"2503_CR23","doi-asserted-by":"publisher","first-page":"14141","DOI":"10.1128\/JVI.79.22.14141-14148.2005","volume":"79","author":"M Faber","year":"2005","unstructured":"Faber M, Faber ML, Papaneri A, Bette M, Weihe E, Dietzschold B, Schnell MJ: A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity. J Virol 2005, 79: 14141-14148. 10.1128\/JVI.79.22.14141-14148.2005","journal-title":"J Virol"},{"key":"2503_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/13550280490279799","volume":"10","author":"M Takayama-Ito","year":"2004","unstructured":"Takayama-Ito M, Ito N, Yamada K, Minamoto N, Sugiyama M: Region at amino acids 164 to 303 of the rabies virus glycoprotein plays an important role in pathogenicity for adult mice. J Neurovirol 2004, 10: 131-135. 10.1080\/13550280490279799","journal-title":"J Neurovirol"},{"key":"2503_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.virusres.2005.08.004","volume":"115","author":"M Takayama-Ito","year":"2006","unstructured":"Takayama-Ito M, Ito N, Yamada K, Sugiyama M, Minamoto N: Multiple amino acids in the glycoprotein of rabies virus are responsible for pathogenicity in adult mice. Virus Res 2006, 115: 169-175. 10.1016\/j.virusres.2005.08.004","journal-title":"Virus Res"},{"key":"2503_CR26","first-page":"95","volume":"131","author":"CE Rupprecht","year":"2008","unstructured":"Rupprecht CE, Barrett J, Briggs D, Cliquet F, Fooks AR, Lumlertdacha B, Meslin FX, Muler T, Nel LH, Schneider C, Tordo N, Wandeler AI: Can rabies be eradicated? Dev Biol (Basel) 2008, 131: 95-121.","journal-title":"Dev Biol (Basel)"},{"key":"2503_CR27","first-page":"103","volume":"125","author":"CE Rupprecht","year":"2006","unstructured":"Rupprecht CE, Hanlon CA, Slate D: Control and prevention of rabies in animals: paradigm shifts. Dev Biol (Basel) 2006, 125: 103-111.","journal-title":"Dev Biol (Basel)"},{"key":"2503_CR28","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.virusres.2008.04.002","volume":"135","author":"J Du","year":"2008","unstructured":"Du J, Zhang Q, Tang Q, Li H, Tao X, Morimoto K, Nadin-Davis SA, Liang G: Characterization of human rabies virus vaccine strain in China. Virus Res 2008, 135: 260-266. 10.1016\/j.virusres.2008.04.002","journal-title":"Virus Res"},{"key":"2503_CR29","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1186\/1743-422X-8-521","volume":"8","author":"W Jiao","year":"2011","unstructured":"Jiao W, Yin X, Li Z, Lan X, Li X, Tian X, Li B, Yang B, Zhang Y, Liu J: Molecular characterization of China rabies virus vaccine strain. Virol J 2011, 8: 521. 10.1186\/1743-422X-8-521","journal-title":"Virol J"},{"key":"2503_CR30","first-page":"431","volume":"24","author":"L Cai","year":"2011","unstructured":"Cai L, Tao X, Liu Y, Zhang H, Gao L, Hu S, Liu F, Li H, Shen X, Liu J, Wang S, Tang Q: Molecular characteristics and phylogenetic analysis of N gene of human derived rabies virus. Biomed Environ Sci 2011, 24: 431-437.","journal-title":"Biomed Environ Sci"},{"key":"2503_CR31","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1128\/JVI.75.7.3268-3276.2001","volume":"75","author":"H Badrane","year":"2001","unstructured":"Badrane H, Bahloul C, Perrin P, Tordo N: Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity. J Virol 2001, 75: 3268-3276. 10.1128\/JVI.75.7.3268-3276.2001","journal-title":"J Virol"},{"key":"2503_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1743-422X-11-85","volume":"11","author":"C Guo","year":"2014","unstructured":"Guo C, Wang C, Luo S, Zhu S, Li H, Liu Y, Zhou L, Zhang P, Zhang X, Ding Y, Huang W, Wu K, Zhang Y, Rong W, Tian H: The adaptation of a CTN-1 rabies virus strain to high-titered growth in chick embryo cells for vaccine development. Virol J 2014, 11: 85-92. 10.1186\/1743-422X-11-85","journal-title":"Virol J"},{"key":"2503_CR33","doi-asserted-by":"publisher","first-page":"7642","DOI":"10.1128\/JVI.76.15.7642-7650.2002","volume":"76","author":"GW Wertz","year":"2002","unstructured":"Wertz GW, Moudy R, Ball LA: Adding genes to the RNA genome of vesicular stomatitis virus: positional effects on stability of expression. J Virol 2002, 76: 7642-7650. 10.1128\/JVI.76.15.7642-7650.2002","journal-title":"J Virol"},{"issue":"Pt 11","key":"2503_CR34","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1099\/0022-1317-79-11-2565","volume":"79","author":"C Prehaud","year":"1998","unstructured":"Prehaud C, Hellebrand E, Coudrier D, Volchkov VE, Volchkova VA, Feldmann H, Le Guenno B, Bouloy M: Recombinant Ebola virus nucleoprotein and glycoprotein (Gabon 94 strain) provide new tools for the detection of human infections. J Gen Virol 1998,79(Pt 11):2565-2572.","journal-title":"J Gen Virol"},{"key":"2503_CR35","first-page":"3","volume":"17","author":"A Diallo","year":"1986","unstructured":"Diallo A: Avirulent mutants of the rabies virus: change in site III of the glycoprotein. Ann Rech Vet 1986, 17: 3-6.","journal-title":"Ann Rech Vet"},{"key":"2503_CR36","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/0042-6822(89)90122-0","volume":"172","author":"C Tuffereau","year":"1989","unstructured":"Tuffereau C, Leblois H, Benejean J, Coulon P, Lafay F, Flamand A: Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice. Virology 1989, 172: 206-212. 10.1016\/0042-6822(89)90122-0","journal-title":"Virology"},{"key":"2503_CR37","doi-asserted-by":"publisher","first-page":"11496","DOI":"10.1128\/JVI.75.23.11496-11502.2001","volume":"75","author":"T Mebatsion","year":"2001","unstructured":"Mebatsion T: Extensive attenuation of rabies virus by simultaneously modifying the dynein light chain binding site in the P protein and replacing Arg333 in the G protein. J Virol 2001, 75: 11496-11502. 10.1128\/JVI.75.23.11496-11502.2001","journal-title":"J Virol"},{"key":"2503_CR38","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1016\/S0264-410X(01)00064-0","volume":"19","author":"K Morimoto","year":"2001","unstructured":"Morimoto K, McGettigan JP, Foley HD, Hooper DC, Dietzschold B, Schnell MJ: Genetic engineering of live rabies vaccines. Vaccine 2001, 19: 3543-3551. 10.1016\/S0264-410X(01)00064-0","journal-title":"Vaccine"},{"key":"2503_CR39","doi-asserted-by":"publisher","first-page":"9121","DOI":"10.1128\/JVI.75.19.9121-9128.2001","volume":"75","author":"N Ito","year":"2001","unstructured":"Ito N, Takayama M, Yamada K, Sugiyama M, Minamoto N: Rescue of rabies virus from cloned cDNA and identification of the pathogenicity-related gene: glycoprotein gene is associated with virulence for adult mice. J Virol 2001, 75: 9121-9128. 10.1128\/JVI.75.19.9121-9128.2001","journal-title":"J Virol"},{"key":"2503_CR40","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1128\/jvi.71.11.8718-8725.1997","volume":"71","author":"JN Barr","year":"1997","unstructured":"Barr JN, Whelan SP, Wertz GW: cis-Acting signals involved in termination of vesicular stomatitis virus mRNA synthesis include the conserved AUAC and the U7 signal for polyadenylation. J Virol 1997, 71: 8718-8725.","journal-title":"J Virol"},{"key":"2503_CR41","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1128\/JVI.72.3.1805-1813.1998","volume":"72","author":"LN Hwang","year":"1998","unstructured":"Hwang LN, Englund N, Pattnaik AK: Polyadenylation of vesicular stomatitis virus mRNA dictates efficient transcription termination at the intercistronic gene junctions. J Virol 1998, 72: 1805-1813.","journal-title":"J Virol"},{"key":"2503_CR42","doi-asserted-by":"publisher","first-page":"11841","DOI":"10.1128\/JVI.01153-10","volume":"84","author":"DL Horton","year":"2010","unstructured":"Horton DL, McElhinney LM, Marston DA, Wood JL, Russell CA, Lewis N, Kuzmin IV, Fouchier RA, Osterhaus AD, Fooks AR, Smith DJ: Quantifying antigenic relationships among the lyssaviruses. J Virol 2010, 84: 11841-11848. 10.1128\/JVI.01153-10","journal-title":"J Virol"},{"key":"2503_CR43","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1586\/erv.11.140","volume":"10","author":"X Wu","year":"2011","unstructured":"Wu X, Smith TG, Rupprecht CE: From brain passage to cell adaptation: the road of human rabies vaccine development. Expert Rev Vaccines 2011, 10: 1597-1608. 10.1586\/erv.11.140","journal-title":"Expert Rev Vaccines"},{"key":"2503_CR44","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.biologicals.2007.06.002","volume":"36","author":"M Manohar","year":"2008","unstructured":"Manohar M, Orrison B, Peden K, Lewis AMJ: Assessing the tumorigenic phenotype of VERO cells in adult and newborn nude mice. Biologicals 2008, 36: 65-72. 10.1016\/j.biologicals.2007.06.002","journal-title":"Biologicals"},{"key":"2503_CR45","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0092-1157(84)80063-3","volume":"12","author":"IS Levenbook","year":"1984","unstructured":"Levenbook IS, Petricciani JC, Elisberg BL: Tumorigenicity of Vero cells. J Biol Stand 1984, 12: 391-398. 10.1016\/S0092-1157(84)80063-3","journal-title":"J Biol Stand"},{"key":"2503_CR46","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0092-1157(84)80019-0","volume":"12","author":"R Barth","year":"1984","unstructured":"Barth R, Gruschkau H, Bijok U, Hilfenhaus J, Hinz J, Milcke L, Moser H, Jaeger O, Ronneberger H, Weinmann E: A new inactivated tissue culture rabies vaccine for use in man. Evaluation of PCEC-vaccine by laboratory tests. J Biol Stand 1984, 12: 29-46. 10.1016\/S0092-1157(84)80019-0","journal-title":"J Biol Stand"},{"key":"2503_CR47","first-page":"147","volume":"40","author":"A Kondo","year":"1978","unstructured":"Kondo A: Pre-immunization and post-exposure treatment with inactivated rabies vaccine of chick embryo cell culture origin (CEC). Dev Biol Stand 1978, 40: 147-153.","journal-title":"Dev Biol Stand"},{"key":"2503_CR48","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/0264-410X(87)90102-2","volume":"5","author":"KG Nicholson","year":"1987","unstructured":"Nicholson KG, Farrow PR, Bijok U, Barth R: Pre-exposure studies with purified chick embryo cell culture rabies vaccine and human diploid cell vaccine: serological and clinical responses in man. Vaccine 1987, 5: 208-214. 10.1016\/0264-410X(87)90102-2","journal-title":"Vaccine"},{"key":"2503_CR49","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jpeds.2007.02.044","volume":"151","author":"T Kamoltham","year":"2007","unstructured":"Kamoltham T, Thinyounyong W, Phongchamnaphai P, Phraisuwan P, Khawplod P, Banzhoff A, Malerczyk C: Pre-Exposure Rabies Vaccination Using Purified Chick Embryo Cell Rabies Vaccine Intradermally is Immunogenic and Safe. J Pediatr 2007, 151: 173-177. 10.1016\/j.jpeds.2007.02.044","journal-title":"J Pediatr"},{"key":"2503_CR50","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1093\/bioinformatics\/btm404","volume":"23","author":"MA Larkin","year":"2007","unstructured":"Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG: Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23: 2947-2948. 10.1093\/bioinformatics\/btm404","journal-title":"Bioinformatics"},{"key":"2503_CR51","first-page":"535","volume":"48","author":"JS Smith","year":"1973","unstructured":"Smith JS, Yager PA, Baer GM: A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ 1973, 48: 535-541.","journal-title":"Bull World Health Organ"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-11-176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T02:16:19Z","timestamp":1689560179000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-11-176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,6]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2503"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-11-176","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,6]]},"assertion":[{"value":"27 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"176"}}